Amal Zaher | Microbial Cell Biology | Best Researcher Award

Posted on by Cell Biologist

Assoc. Prof. Dr. Amal Zaher | Microbial Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Amal Zaher , Beni-suef University , Egypt

Dr. Amal Zaher Shehata Mohamad is an Egyptian chemical and environmental engineering researcher with over two decades of academic and industrial experience. Born on March 6, 1978, she currently serves as an Associate Professor at the Department of Environmental Science and Industrial Development, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, Egypt. Dr. Zaher’s work bridges environmental sustainability and nanotechnology, focusing on wastewater treatment and advanced material applications. With a strong background in safety and occupational health, her research integrates real-world industry needs with academic innovation. She has published extensively in high-impact journals and has contributed to book chapters and international conferences. Her collaborative nature and interdisciplinary expertise have made her a respected voice in environmental science across Egypt and beyond.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Extensive Research Output: Dr. Zaher has authored over 20 peer-reviewed articles, conference papers, and book chapters, covering highly relevant environmental topics like wastewater treatment, nanotechnology, and advanced materials.

  2. Interdisciplinary Expertise: She bridges chemical engineering and environmental science, with a strong focus on Layered Double Hydroxides (LDHs), MOFs, nanofibers, and photocatalysis, demonstrating deep technical versatility.

  3. Real-World Relevance: Her research is oriented toward practical environmental applications—such as the degradation of pollutants and water purification—contributing to sustainable development and public health.

  4. Longstanding Academic and Industrial Experience: Dr. Zaher combines over 20 years of experience in engineering practice, health & safety, and academic teaching, giving her research both depth and applicability.

  5. Global Contributions: Participation in international conferences and publication in high-impact journals (e.g., Fuel, Scientific Reports, Environmental Science and Pollution Research) demonstrates global recognition.

  6. Leadership and Mentorship: As an Associate Professor, she plays a key role in mentoring postgraduate students, leading interdisciplinary projects, and promoting research at Beni-Suef University.

🔄 Areas for Improvement:

  1. International Collaborations: While she has collaborated widely within Egypt, expanding joint projects with international institutions or labs would elevate her global research profile.

  2. Patent or Commercial Applications: Filing patents or translating her nanomaterials research into industrial or commercial solutions would further enhance her impact.

  3. Research Funding and Grants: More visibility in securing or leading national/international research grants would strengthen her academic leadership credentials.

  4. Citation Impact: While she publishes frequently, focused efforts on publishing in journals with higher citation indices or review papers may increase her scientific impact.

🎓 Education:

Dr. Amal Zaher holds a B.Sc. with Honors in Chemical Engineering from Minia University, Egypt (2000). She later earned her M.Sc. in Chemical Engineering from the same institution in 2006 with a thesis focused on innovative techniques for treating oil-polluted wastewater. Driven by her interest in sustainable environmental technologies, she continued her academic pursuits and received her Ph.D. in Environmental Science and Industrial Development, further enhancing her knowledge in advanced oxidation processes and nanomaterials for wastewater treatment. Her educational background merges rigorous engineering principles with environmental applications, making her a versatile researcher in tackling industrial pollution challenges. Her academic training provided the foundation for a distinguished career in teaching, safety management, and cutting-edge scientific research.

💼 Experience:

Dr. Amal Zaher began her professional journey as a freelance engineer (2000–2002) before working as a specialist in safety and occupational health at the Manpower and Immigration Department in Minia, Egypt (2002–2016). She transitioned into academia in 2013 as an Assistant Professor at the Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University (BSU), later promoted to Associate Professor. With her diverse background, she has contributed significantly to environmental safety and pollution control both in practice and in theory. Her hands-on experience in industrial environments enhances her teaching and research, enabling her to address real-world problems with academic solutions. Dr. Zaher has led and collaborated on numerous projects related to wastewater treatment, nanomaterials, and environmental remediation, establishing herself as an expert and mentor in the field.

🔬 Research Focus:

Dr. Amal Zaher’s research centers around advanced materials and processes for environmental remediation, particularly in water and wastewater treatment. Her work explores the use of layered double hydroxides (LDH), metal-organic frameworks (MOFs), and nanostructures in removing pollutants like heavy metals, pharmaceuticals, and dyes. She is known for her contributions to photocatalytic degradation using processes such as Photo-Fenton and her innovative use of zeolite templates and metal doping to enhance adsorptive efficiency. Her recent projects delve into electrocatalytic and antibacterial applications of nanomaterials, as well as solar desalination. Her multidisciplinary approach—combining chemical engineering, environmental science, and materials chemistry—supports sustainable water management. Through publications, book chapters, and international presentations, Dr. Zaher has advanced global knowledge on pollution control and eco-friendly technologies.

📚 Publications Top Notes:

  1. ⚗️ Using Advanced Oxidation Process for Oily Water Clean-up

  2. 🌿 Optimization of a Simulated Photo-Fenton Process for Treating Olive Mill Wastewater

  3. 🔬 Influences of Tungsten Incorporation on Ni/C Nanostructures for Urea Elimination

  4. 💊 Zn/Fe LDH for Removal of Oxytetracycline: Experimental & Molecular Simulations

  5. 🌞 Photocatalytic Degradation of Phenol Wastewater: Photo Fenton Optimization

  6. 🧪 Nickel Doped Carbon Nanofibers with Tungsten for Ethanol Oxidation

  7. 💧 La-doped Zn-Fe LDH for Tetracycline Adsorption from Water

  8. 🧱 LDH Nanocubes with Zeolite Templates for Adsorbent Applications

  9. 🎨 Physicochemical Properties of Zn–Fe LDH for Dye Removal

  10. 🧼 Photocatalytic Degradation of Dye Wastewater with ZnO Nanoparticles

📌 Conclusion:

Dr. Amal Zaher Shehata Mohamad is a highly suitable candidate for the Best Researcher Award. Her work stands out for its relevance, innovation, and impact in solving critical environmental challenges through scientific research. With her impressive record of publications, dedication to teaching and mentoring, and alignment with sustainable development goals, she exemplifies the caliber of a leading researcher. Addressing a few strategic improvements could make her a globally recognized name in environmental science and nanotechnology.

Majid Komijani | Microbial Cell Biology | Best Researcher Award

Posted on by Cell Biologist

Assoc. Prof. Dr. Majid Komijani | Microbial Cell Biology | Best Researcher Award

Assoc. Prof. Dr. Majid Komijani , Arak University , Iran

Majid Komijani is an Associate Professor of Microbiology at Arak University, Iran. With over 33 published articles, 11 under review, and two patents, his research spans microbiology, focusing on viruses, bacteria, and their roles in neurological diseases. Komijani holds key leadership roles in various scientific societies, including his position as Director-in-Charge of the Journal of Neurobiology Research. He is also an active reviewer for publishers such as MDPI. His work has contributed significantly to the study of microbiota, virology, antibiotic resistance, and phage therapy. Besides his academic contributions, Komijani has undertaken significant research in environmental microbiology, investigating pollution in aquatic ecosystems. His innovative work has garnered him a broad research network and significant citations in the scientific community.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Extensive Research Contribution: Dr. Komijani has authored 33 published articles and has numerous ongoing publications and patents. His interdisciplinary approach to microbiology, particularly in the context of viruses, bacteria, and neurological diseases, makes a substantial contribution to the field. The citation index of 482 further emphasizes the influence of his work.
  2. Innovative Research: Dr. Komijani has developed diagnostic kits for viral detection, such as the BK virus and CMV detection kits, which highlight his focus on practical and impactful innovations in medical diagnostics.
  3. Multidisciplinary Expertise: His research spans bacteriophage therapy, antibiotic resistance, virology, and neuroscience, which speaks to his broad expertise and the interdisciplinary nature of his work. This is further enhanced by his collaboration with international researchers.
  4. Leadership and Mentorship: As Director-in-Charge of the Journal of Neurological Research (https://jnr.araku.ac.ir/), he plays a significant role in shaping the research environment and mentoring young scholars in the field.
  5. Industry Collaboration: His consultancy projects, particularly in the metagenomic analysis of environmentally polluting bacteria, underscore his engagement with real-world problems and collaboration with industries.
  6. Recognition and Academic Contributions: His book publications and regular involvement in academic society activities, including being a reviewer for journals like MDPI, underline his contribution to advancing scientific knowledge.

Areas for Improvement:

  1. Global Outreach: While Dr. Komijani has impressive international collaborations, expanding his visibility in global scientific communities or participating in larger-scale, international research consortia could further amplify the impact of his work.
  2. Research Diversity: Although he has extensive experience in viral infections and bacteriology, further broadening the scope of his research into emerging areas such as microbiome research and their link with chronic diseases could add depth to his expertise.
  3. Public Engagement: Engaging more with the public or organizing workshops to translate his scientific findings into more accessible formats could elevate his work’s visibility outside academic circles.

Education:

Majid Komijani earned his Ph.D. in Microbiology from Arak University, Iran, where he is now an esteemed faculty member. His educational journey and research have consistently focused on microbiology, with a particular emphasis on virology, bacteriology, and the relationship between infections and diseases. As an academic, he has mentored numerous graduate and doctoral students, contributing to the advancement of microbiological studies at Arak University. He has also engaged in interdisciplinary collaborations with researchers in other countries, further enhancing the scope of his education and research. Through his extensive education, Komijani has developed deep expertise in the molecular mechanisms underlying viral and bacterial infections, their roles in human health, and the development of therapeutic solutions like phage therapy. His commitment to education, scientific rigor, and the dissemination of knowledge is evident through his various teaching and research roles.

Experience:

Dr. Majid Komijani has extensive experience as an Associate Professor of Microbiology at Arak University, where he has led numerous research projects, particularly in the areas of virology, bacteriology, and environmental microbiology. He has worked on projects investigating the role of infectious agents in neurological diseases and antibiotic resistance, and has explored novel bacteriophage therapies. Komijani has been instrumental in contributing to the academic field, publishing 33 articles, with many appearing in SCI-indexed journals, and securing two patents for diagnostic kits. His research has a broad scope, encompassing both environmental pollution and the effects of infectious agents on human health. As a consultant, Komijani has actively collaborated with industries and organizations in tackling the environmental impact of bacteria, particularly in water ecosystems. Furthermore, his work on phage therapy as an alternative to antibiotics reflects his forward-thinking approach in microbiological research.

Research Focus:

Dr. Majid Komijani’s research primarily focuses on the role of viruses and bacteria in neurological diseases, particularly the impact of cytomegalovirus (CMV) and other viral infections in conditions like multiple sclerosis. His work on the microbiome has expanded into understanding the impact of environmentally polluting bacteria and how antibiotic resistance emerges in natural ecosystems. Through metagenomic analyses, he has investigated bacteria in aquatic environments, particularly rivers and iron mine waters, revealing the spread of resistance genes. Komijani is also passionate about phage therapy, having designed bacteriophages targeting multi-drug-resistant pathogens like Klebsiella pneumoniae and Acinetobacter baumannii. His innovative diagnostic kits for BK virus and CMV reflect his commitment to practical, clinically applicable solutions. Komijani continues to investigate the intricate balance between bacterial and viral interactions in neurological diseases and environmental microbiology, always aiming to advance both the scientific understanding and treatment methodologies in these fields.

Publications Top Notes:

  • Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis 🦠🧠
  • Torque Teno Mini Virus Infection and Multiple Sclerosis 🧠🦠
  • Detection and Characterization of a Novel Lytic Bacteriophage (vB-KpneM-Isf48) Against Klebsiella pneumoniae Isolates from Infected Wounds Carrying Antibiotic-Resistance Genes (TEM, SHV, and CTX-M) 🔬🦠
  • Detection of Herpes Simplex Virus Infection in Cerebrospinal Fluid 🧠💉
  • Detection of antibiotic resistance genes (TEM, SHV and CTX-M) in Escherichia coli isolated from infected wounds 🦠🔬
  • Comparison of Real-Time Polymerase Chain Reaction and pp65 Antigen Assay for Monitoring the Development of Cytomegalovirus Disease in Recipients of Kidney Transplant 🧬💉
  • Prevalence of Extended-Spectrum β-Lactamases Genes in Clinical Isolates of Pseudomonas aeruginosa 🦠🔬
  • Isolation, characterization, and PCR-based molecular identification of a siphoviridae phage infecting Shigella dysenteriae 🦠🧬
  • A New Phage Cocktail Against Multidrug, ESBL-Producer Isolates of Shigella sonnei and Shigella flexneri with Highly Efficient Bacteriolytic Activity 🦠💊
  • Synthesis of new environmentally friendly poly(urethane-imide)s as an adsorbent including β-cyclodextrin cavities and attached to iron nanoparticles for removal of gram-positive and gram-negative bacteria from water samples 🌍🔬

Conclusion:

Dr. Majid Komijani is an outstanding candidate for the Best Researcher Award. His substantial contributions to microbiology, particularly in infectious diseases and their impact on neurological health, combined with his innovative work in diagnostics and therapeutic solutions, make him a leader in his field. His commitment to interdisciplinary research, international collaboration, and mentorship of future scientists positions him as an exemplary figure in academic research. While his global engagement and broader public visibility could be areas for growth, his impact on the field remains profound and deserving of recognition.

 

 

 

Alexander Chernov | Microbial Cell Biology | Best Scholar Award

Posted on by Cell Biologist

Dr. Alexander Chernov | Microbial Cell Biology | Best Scholar Award

Dr. Alexander Chernov , Institute of Experimental Medicine , Russia

Alexandr Nikolaevich Chernov is a senior researcher at the Institute of Experimental Medicine, Saint Petersburg, Russia, and an assistant at the Saint Petersburg State Pediatric Medical University. He has a strong background in biochemistry and pathological physiology, with expertise in the molecular and cellular mechanisms affecting cancer treatment and brain tumors. With over 139 scientific publications, including numerous articles in peer-reviewed journals, he has significantly contributed to the field of cancer research. His work explores the effects of growth factors, innate immunity peptides, and chemotherapy on brain tumor cells. Chernov has also received multiple awards, including the Scholarship of the President of the Republic of Belarus. He continues to advance his research through collaborations and projects in Russia, Belarus, and Israel. His dedication to science is evident in his extensive research portfolio, editorial work, and mentorship roles, especially in cancer research.

Publication Profile:

Orcid

Strengths for the Award:

  1. Extensive Research Experience: Alexandr Chernov has an impressive background in biomedical research, with 139 scientific publications, including 86 in peer-reviewed journals. His research spans a wide range of topics including molecular mechanisms in brain tumors, innate immunity peptides, and chemotherapy drugs, demonstrating a strong commitment to advancing scientific knowledge.
  2. Innovation and Impact: Chernov has authored 8 patents and contributed to groundbreaking studies, such as those related to the anticancer effects of peptides and growth factors in glioma and other tumors. His recent studies on Streptococcus pyogenes’ oncolytic activity against various cancers reflect a significant contribution to cancer therapy.
  3. Grant Leadership: He has successfully led multiple significant research grants, including those funded by the Belarusian Republican Foundation for Fundamental Research. These grants focus on key areas like oncogenesis and cancer treatment, reinforcing his leadership in cutting-edge research.
  4. High Citation Index: With 474 citations in Google Scholar and a citation index of 10, Chernov’s work is well-respected and widely referenced by his peers, indicating that his research is impactful and influential in the scientific community.
  5. Global Collaboration: His research collaborations extend internationally, such as his recent internship at Ben-Gurion University in Israel. This global network is essential for advancing scientific research and fostering innovation.
  6. Contributions to Academia and Education: As a senior researcher and educator at the Saint Petersburg State Pediatric Medical University, Chernov is also involved in mentoring the next generation of researchers, ensuring the continued growth of his field.

Areas for Improvement:

  1. Broader Outreach and Public Engagement: While Chernov’s work is highly technical and impactful in the scientific community, expanding efforts to communicate these results to the broader public or through interdisciplinary collaborations could enhance the reach and societal impact of his research.
  2. Diversifying Research Publications: Although Chernov has numerous publications in high-impact journals, a greater variety of research topics, including interdisciplinary studies, might expand his work’s applicability in other scientific and clinical fields.
  3. Industry Collaboration: While Chernov has a solid academic foundation, increased collaboration with industry stakeholders could lead to practical, real-world applications of his discoveries in medical devices or treatments.

Education:

Chernov’s educational journey began at Belarusian State University, where he earned a degree from the Biological Faculty in 2005, specializing in Biochemistry. He then advanced his studies with a postgraduate program in Human Physiology at the Institute of Physiology of the National Academy of Sciences of Belarus, completing it in 2012. His professional career continued with roles at leading research institutes, including his current positions in Russia. In 2021, Chernov defended his PhD thesis at the Institute of Experimental Medicine, Saint Petersburg, focusing on the effects of nerve growth factors and peptides on brain tumor cells. Chernov further broadened his expertise through a research internship at Ben-Gurion University, Israel, between 2021-2022. His academic journey reflects a deep commitment to understanding cancer biology, particularly in the context of brain tumor therapies and innovative treatment combinations.

Experience:

Chernov has extensive research experience spanning nearly two decades. He started his professional career as a Junior Researcher at the Institute of Physiology of the National Academy of Sciences of Belarus from 2005 to 2016. His research focused on the cellular and molecular mechanisms of growth factors in oncology. In 2017-2018, he further honed his expertise at the Almazov National Medical Research Center in Saint Petersburg, contributing to translational medical research. From 2018 to 2020, he worked at City Hospital 40, Saint Petersburg, gaining clinical insights into treatment modalities. Since 2020, he has been a Senior Researcher at the Institute of Experimental Medicine, continuing groundbreaking work in cancer therapy and biological chemistry. Chernov has collaborated internationally, including a research internship in Israel. His leadership roles extend to heading several research grants and projects in Belarus, Russia, and global scientific networks, further enriching his interdisciplinary experience.

Awards and Honors:

Chernov’s outstanding scientific contributions have earned him numerous accolades. Among his most significant honors is the Scholarship of the President of the Republic of Belarus (2012), awarded for his exceptional work as a postgraduate student. Throughout his career, he has been recognized for his leadership in research projects, including as the head of several grants funded by the Belarusian Republican Foundation for Fundamental Research. His innovations in cancer research and contributions to the understanding of brain tumors and growth factors have also been acknowledged internationally. Chernov has received recognition from peers and scientific organizations, cementing his role as a distinguished researcher in his field. In addition to these prestigious awards, his teaching role at Saint Petersburg State Pediatric Medical University since 2024 highlights his ongoing commitment to education and mentorship in the scientific community.

Research Focus:

Chernov’s primary research focus lies in the molecular and cellular mechanisms that govern the interaction of growth factors (e.g., nerve growth factor) and innate immunity peptides (such as LL-37 and PG-1) with chemotherapy drugs in treating central nervous system tumors. His groundbreaking research addresses the oncolytic potential of these peptides and their combinations with chemotherapy drugs to enhance cancer cell death and improve patient outcomes in brain tumors. He is particularly interested in understanding the underlying molecular mechanisms, including mitochondrial metabolism, proliferation, and migration in glioma cells, with the aim of developing new treatment strategies for gliomas and other malignancies. His work also explores the effects of bacterial strains and antimicrobial peptides on tumor cells, investigating innovative approaches to cancer therapy. Chernov has demonstrated significant expertise in the areas of tumor biology, oncolytic therapy, and drug resistance, contributing to advancements in predictive oncology and personalized medicine.

Publications Top Notes:

  1. The Benefits of Whole-Exome Sequencing in the Differential Diagnosis of Hypophosphatasia 🧬
  2. Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1 🧠
  3. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity of COVID-19 🦠
  4. Pharmacogenetic Study of the Impact of ABCB1 SNPs on Cyclosporine Response 💊
  5. Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor, and Temozolomide 💥
  6. Molecular Mechanisms of Drug Resistance in Glial Tumors 🧬
  7. Secretory Phospholipase A2: Biomarker of Inflammation in Autoimmune, Bacterial, and Viral Diseases 🔬
  8. Identification of Genetic Risk Factors for Severe COVID-19 in Russian Patients 🧬
  9. In Vitro Evaluation of Cytotoxic Effect of Streptococcus pyogenes and Peptides on Glioma Cells 🦠
  10. Molecular Mechanisms of Glioblastoma Multiforme Drug Resistance 🔬

Conclusion:

Alexandr Chernov is a highly qualified candidate for the “Best Research Scholar Award” due to his significant contributions to the fields of pathology, oncology, and immunology. His extensive publication record, successful leadership in grants, high citation index, and global research collaborations demonstrate his standing as a top-tier researcher. While expanding his outreach and collaboration with industry could further enhance his impact, his current work already stands as a noteworthy contribution to the advancement of scientific knowledge and healthcare. His selection for this award would be a recognition of his ongoing dedication to research excellence and innovation in medical science.